DaVita Return on Investment 2010-2024 | DVA

Current and historical return on investment (ROI) values for DaVita (DVA) over the last 10 years.
DaVita ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-03-31 $1.78B $10.13B 18.15%
2023-12-31 $1.60B $9.51B 16.69%
2023-09-30 $1.47B $9.66B 15.27%
2023-06-30 $1.29B $9.80B 13.39%
2023-03-31 $1.31B $9.44B 13.67%
2022-12-31 $1.34B $9.57B 13.85%
2022-09-30 $1.47B $9.57B 15.18%
2022-06-30 $1.64B $9.84B 16.64%
2022-03-31 $1.69B $9.71B 17.03%
2021-12-31 $1.80B $9.67B 17.84%
2021-09-30 $1.79B $10.10B 17.85%
2021-06-30 $1.75B $10.26B 17.69%
2021-03-31 $1.67B $10.26B 16.90%
2020-12-31 $1.70B $9.48B 16.99%
2020-09-30 $1.78B $9.62B 17.45%
2020-06-30 $1.72B $10.23B 16.49%
2020-03-31 $1.77B $10.58B 17.24%
2019-12-31 $1.64B $10.30B 16.31%
2019-09-30 $1.57B $10.53B 14.91%
2019-06-30 $1.48B $9.62B 13.44%
2019-03-31 $1.46B $9.87B 12.37%
2018-12-31 $1.53B $12.08B 11.90%
2018-09-30 $1.29B $12.47B 9.68%
2018-06-30 $1.39B $12.66B 10.20%
2018-03-31 $1.35B $14.06B 9.59%
2017-12-31 $1.81B $14.04B 12.86%
2017-09-30 $2.18B $13.88B 15.53%
2017-06-30 $2.60B $14.18B 18.48%
2017-03-31 $2.54B $14.26B 18.13%
2016-12-31 $2.03B $13.79B 14.58%
2016-09-30 $1.72B $14.09B 12.32%
2016-06-30 $1.41B $13.92B 10.07%
2016-03-31 $1.57B $13.90B 11.05%
2015-12-31 $1.14B $14.09B 8.07%
2015-09-30 $1.38B $14.27B 9.85%
2015-06-30 $1.31B $14.45B 9.47%
2015-03-31 $1.31B $13.55B 9.69%
2014-12-31 $1.82B $13.66B 13.58%
2014-09-30 $1.85B $13.53B 14.06%
2014-06-30 $1.79B $13.35B 13.84%
2014-03-31 $1.82B $12.91B 14.36%
2013-12-31 $1.55B $12.75B 12.37%
2013-09-30 $1.45B $12.62B 11.72%
2013-06-30 $1.42B $12.52B 12.53%
2013-03-31 $1.14B $12.23B 11.53%
2012-12-31 $1.30B $12.24B 15.15%
2012-09-30 $1.26B $8.29B 17.61%
2012-06-30 $1.24B $6.90B 18.46%
2012-03-31 $1.24B $6.80B 18.98%
2011-12-31 $1.16B $6.69B 17.98%
2011-09-30 $1.05B $6.50B 16.66%
2011-06-30 $0.99B $6.16B 16.23%
2011-03-31 $0.99B $6.36B 16.49%
2010-12-31 $0.99B $6.27B 17.00%
2010-09-30 $0.98B $5.64B 17.16%
2010-06-30 $0.97B $5.64B 16.91%
2010-03-31 $0.96B $5.83B 16.82%
2009-12-31 $0.94B $5.73B 16.65%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $11.923B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $16.063B 16.60
Encompass Health (EHC) United States $8.608B 22.03
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Amedisys (AMED) United States $3.202B 22.68
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
U.S Physical Therapy (USPH) United States $1.424B 38.10
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00